The COVID-19 pandemic has had a significant impact on communities across the United States (US). Three vaccines have now been granted Emergency Use Authorization by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) for use in the US. However, barriers to vaccination exist, some of which are well documented in the literature, including lack of knowledge, fear, accessibility, mistrust in the healthcare system, and systemic and operational obstacles. Vaccine hesitancy in the US could potentially hinder all the efforts and resources being used to beat COVID-19, which has resulted in more than 594 000 deaths in the US per the CDC as of early June 2021. In order to overcome this pandemic, vaccine distribution and uptake is crucial. Pharmacists play a crucial role as healthcare providers as they can dismantle vaccine hesitancy and make an outstanding impact on the efforts to overcome this pandemic.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047593 | PMC |
| http://dx.doi.org/10.1177/08971900221081621 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children.
Hum Vaccin Immunother
December 2025
Department of Health, Psychology and Social Care, University of Derby, Derby, UK.
The COVID-19 pandemic has significantly altered public perceptions of vaccines, particularly among parents. In high-income countries like the United Kingdom (UK) and Australia, factors such as misinformation, the expedited approval process of COVID-19 vaccines and unique local challenges have contributed to vaccine hesitancy, resulting in uneven uptake across various vaccination programs. Despite efforts like school-based influenza vaccination programs in the UK and free influenza vaccines in Australia, vaccination rates continue to decline.
View Article and Find Full Text PDFChallenges to promoting maternal respiratory syncytial virus vaccination in Japan.
Vaccine
January 2025
Division of Epidemiology, School of Public Health, Tohoku University Graduate School of Medicine, Japan.
Pfizer's Abrysvo vaccine is highly effective in preventing severe lower respiratory tract illness in those at high risk from the Respiratory Syncytial Virus (RSV). Japan, like other countries, is promoting RSV vaccination among pregnant women, but it needs to do better. However, Japan is enduring a state of broad vaccine hesitancy.
View Article and Find Full Text PDFDelay discounting predicts COVID-19 vaccine booster willingness.
Cogn Res Princ Implic
January 2025
Department of Psychology and Centre for Integrative and Applied Neuroscience, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Developing ways to predict and encourage vaccine booster uptake are necessary for durable immunity responses. In a multi-nation sample, recruited in June-August 2021, we assessed delay discounting (one's tendency to choose smaller immediate rewards over larger future rewards), COVID-19 vaccination status, demographics, and distress level. Participants who reported being vaccinated were invited back one year later (n = 2547) to report their willingness to receive a booster dose, along with reasons for their decision.
View Article and Find Full Text PDFAddressing Vaccine Hesitancy: Validating the PACV Survey for Croatian Parents.
Infect Dis Rep
January 2025
University Department of Health Studies, University of Split, Ruđera Boškovića 35, 21000 Split, Croatia.
Vaccine hesitancy, recognized by the WHO as a significant global health threat, undermines vaccination efforts. This study aimed to adapt and validate the Parent Attitudes about Childhood Vaccines (PACV) Survey for Croatian parents to understand vaccine hesitancy better. A cross-sectional study with 1814 Croatian parents was conducted using the PACV survey, translated using a double-back translation method.
View Article and Find Full Text PDFChallenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar.
Front Allergy
January 2025
Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Introduction: COVID-19 vaccination has been a key intervention in reducing the severity of symptoms; however, concerns about vaccine safety, particularly regarding allergic reactions, arose early on. Healthcare workers faced the challenge of addressing these concerns to ensure safe vaccine administration. This study aimed to review the practical aspects of using allergy skin testing for COVID-19 vaccine excipients in patients with a history of allergic reactions developed following mRNA COVID-19 vaccination.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!